Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | -16.79%98.82M | -27.67%24.06M | -10.84%26.72M | -11.21%22.56M | -15.41%25.49M | 417.70%118.76M | 684.62%33.26M | --29.96M | --25.4M | --30.13M |
Other non cashItems | -41.04%-6.85M | -570.68%-6.79M | 1,149.91%5.97M | -164.12%-3.67M | -25.30%-2.37M | -23.54%-4.86M | 47.16%-1.01M | ---569K | ---1.39M | ---1.89M |
Change in working capital | 117.48%10.84M | 92.75%17.65M | 4.22%-7.52M | -54.78%2.12M | -39.84%-1.41M | -10.78%4.98M | 168.91%9.16M | ---7.85M | --4.68M | ---1.01M |
-Change in receivables | 462.70%2.77M | 798.94%7.23M | -87.05%-6.4M | -31.86%601K | -52.49%1.34M | 44.15%-764K | 72.03%-1.04M | ---3.42M | --882K | --2.81M |
-Change in prepaid assets | 798.60%16.1M | 3,596.36%6.1M | 1,837.85%11.01M | 4,407.69%586K | -251.91%-1.59M | 266.23%1.79M | -22.54%165K | --568K | --13K | --1.05M |
-Change in other current liabilities | -1,408.39%-5.61M | -173.46%-667K | -91,180.00%-4.56M | -1,374.42%-634K | 158.47%252K | 136.42%429K | 123.65%908K | ---5K | ---43K | ---431K |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -104.85%-9.53M | -30.16%54.77M | -115.89%-10.13M | -863.66%-63.54M | -79.57%9.37M | 23.99%196.38M | 49.67%78.42M | --63.77M | --8.32M | --45.87M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | 552.59%111.74M | -176.90%-19.5M | 278.90%82.3M | 986.74%106.02M | -313.38%-57.07M | 61.14%-24.69M | 178.31%25.36M | ---46M | --9.76M | ---13.81M |
Net commonstock issuance | --0 | --0 | --0 | ---- | ---- | -108.10%-2.3M | --0 | --0 | ---- | ---- |
Cash dividends paid | -13.08%-139.62M | -43.71%-35.64M | -119.36%-54.39M | -0.00%-24.8M | 49.48%-24.8M | -85.06%-123.48M | -7.81%-24.8M | ---24.8M | ---24.8M | ---49.09M |
Net other financing activities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 77.22%-36.76M | -12,018.69%-63.77M | 139.40%27.9M | 387.10%80.98M | -30.17%-81.87M | -58.34%-161.36M | 100.95%535K | ---70.8M | ---28.2M | ---62.9M |
Net cash flow | ||||||||||
Beginning cash position | 40.23%122.13M | 96.54%84.81M | 33.55%67.04M | -29.19%49.61M | 40.23%122.13M | 184.63%87.09M | 25.19%43.15M | --50.2M | --70.06M | --87.09M |
Current changes in cash | -232.19%-46.29M | -111.39%-8.99M | 352.65%17.76M | 187.67%17.43M | -325.88%-72.5M | -38.00%35.02M | 2,201.62%78.96M | ---7.03M | ---19.88M | ---17.02M |
Effect of exchange rate changes | -400.00%-48K | -240.00%-28K | 131.25%5K | -137.50%-6K | -375.00%-19K | 60.00%16K | 117.86%20K | ---16K | --16K | ---4K |
End cash position | -37.95%75.79M | -37.95%75.79M | 96.54%84.81M | 33.55%67.04M | -29.19%49.61M | 40.23%122.13M | 299.14%122.13M | --43.15M | --50.2M | --70.06M |
Free cash flow | -104.85%-9.53M | -30.16%54.77M | -115.89%-10.13M | -863.66%-63.54M | -79.57%9.37M | 23.99%196.38M | 49.67%78.42M | --63.77M | --8.32M | --45.87M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |